Pharmacists' review of medicine during admission to hospital
| ISRCTN | ISRCTN08043800 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN08043800 |
| Secondary identifying numbers | N/A |
- Submission date
- 04/03/2010
- Registration date
- 06/04/2010
- Last edited
- 17/11/2010
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English Summary
Not provided at time of registration
Contact information
Ms Trine R. H. Nielsen
Scientific
Scientific
Ringstedgade 63
Naestved
DK-4700
Denmark
| trn@regionsjaelland.dk |
Study information
| Study design | Multicentre interventional prospective randomised clinical controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Prevention |
| Participant information sheet | Not available in web format, please use contact details below to request a patient information sheet. |
| Scientific title | Pharmaceutical optimization of the medication process during admission to hospital: A multicentre, randomised, controlled trial |
| Study acronym | POMP |
| Study hypothesis | A pharmaceutical intervention consisting of: review and use of patient 'sown drugs, secondary medication history, medication review and entry of proposed prescriptions in the electronic medication system will reduce the number of adverse drug events during hospital stay. |
| Ethics approval(s) | Approval by the Danish Ethics Committee is not applicable since the study is not of biomedical nature |
| Condition | In-hospital adverse drug events |
| Intervention | Please note that the anticipated end date for this trial has been extended from 01/11/10 to 31/03/10. Intervention Group 1. Review and use of patient own drugs by clinical pharmacist. 2. Clinical pharmacist taking secondary medication history. 3. Medication review by clinical pharmacist. 4. Entry of proposed prescriptions in the electronic medication system by pharmacist, ready for approval by doctor. The intervention takes place on the day the patient is admitted, and the duration of the intervention is approximately 1.5 hours. Control Group Standard care with no pharmacist involvement There is no follow up examination, but re-admission rates will be noted for 1 year post intervention. |
| Intervention type | Other |
| Primary outcome measure | Number of patients with in-hospital adverse drug events, detected by Adverse Drug Event Trigger Tool. |
| Secondary outcome measures | 1. Length of hospital stay 2. Number of readmissions during the first year after admission 3. Direct cost for the hospital |
| Overall study start date | 08/03/2010 |
| Overall study end date | 31/03/2011 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Both |
| Target number of participants | 648 (across 3 centres) |
| Participant inclusion criteria | 1. Patients being admitted to an internal medicine ward 2. Age 18 years or more 3. Taking 4 types of medicine or more each day 4. Able to understand participant's information written in Danish |
| Participant exclusion criteria | 1. Patients transferred from other hospitals in the area 2. Dying or terminally ill patients 3. Patients being discharged within 48 hours from admission |
| Recruitment start date | 08/03/2010 |
| Recruitment end date | 31/03/2011 |
Locations
Countries of recruitment
- Denmark
Study participating centre
Ringstedgade 63
Naestved
DK-4700
Denmark
DK-4700
Denmark
Sponsor information
Region Zealand Hospital Pharmacy (Region Sjaelland Sygehusapoteket) (Denmark)
Other
Other
Ringstedgade 63
Naestved
DK-4700
Denmark
"ROR" |
https://ror.org/01dtyv127 |
|---|
Funders
Funder type
Government
Region Zealand (Region Sjaelland) (Denmark)
No information available
Region Zealand Hospital Pharmacy (Region Sjaelland Sygehusapoteket) (Denmark)
No information available
Hospital pharmacists and Amgros' Research and Development (Sygehusapotekernes- og Amgros Forsknings- og udviklingsfond) (Denmark)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
